Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Application - 2011

[Federal Register Volume 76, Number 128 (Tuesday, July 5, 2011)]
[Notices]
[Page 39127]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-16791]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Application

Pursuant to Sec. 1301.33(a), Title 21 of the Code of Federal Regulations (CFR), this is notice that on May 16, 2011, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor, Michigan 48108, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Drug Schedule
Cathinone (1235) I
Methcathinone (1237) I
N-Ethylamphetamine (1475) I
N-N-Dimethylamphetamine (1480) I
Aminorex (1585) I
4-Methylaminorex (cis isomer) (1590) I
1-Pentyl-3-(1-naphthoyl)indole (7118) I
1-Butyl-3-(1-naphthoyl)indole (7173) I
1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl) Indole (7200) I
Alpha-ethyltryptamine (7249) I
5-(1,1-Dimethulheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (7297) I
5-(1,1-Dimethyloctyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol (7298) I
Lysergic acid diethylamide (7315) I
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (7348) I
Marihuana (7360) I
Tetrahydrocannabinols (7370) I
3,4,5-Trimethoxyamphetamine (7390) I
4-Bromo-2,5-dimethoxyamphetamine (7391) I
4-Bromo-2,5-dimethoxyphenethylamine (7392) I
4-Methyl-2,5-dimethoxyamphetamine (7395) I
2,5-Dimethoxyamphetamine (7396) I
2,5-Dimethoxy-4-ethylamphetamine (7399) I
3,4-Methylenedioxyamphetamine (7400) I
5-Methoxy-3,4-methylenedioxyamphetamine (7401) I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) I
3,4-Methylenedioxy-N-ethylamphetamine (7404) I
3,4-Methylenedioxymethamphetamine (7405) I
4-Methoxyamphetamine (7411) I
5-Methoxy-N-N-dimethyltryptamine (7431) I
Alpha-methyltryptamine (7432) I
Diethyltryptamine (7434) I
Dimethyltryptamine (7435) I
5-Methoxy-N,N-diisopropyltryptamine (7439) I
Amphetamine (1100) II
Methamphetamine (1105) II
Lisdexamfetamine (1205) II

The company plans to manufacture small quantities of marihuana derivatives for research purposes. In reference to drug code 7360 (Marihuana), the company plans to bulk manufacture cannabidol. In reference to drug code 7370 (Tetrahydrocannabinols), the company will manufacture a synthetic THC. No other activity for this drug code is authorized for this registration.

Any other such applicant, and any person who is presently registered with DEA to manufacture such substances, may file comments or objections to the issuance of the proposed registration pursuant to 21 CFR 1301.33(a).

Any such written comments or objections should be addressed, in quintuplicate, to the Drug Enforcement Administration, Office of Diversion Control, Federal Register Representative (ODL), 8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed no later than September 6, 2011.

Dated: June 23, 2011.

Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 2011-16791 Filed 7-1-11; 8:45 am]

BILLING CODE 4410-09-P

 

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility